BRISTOL-MYERS SQUIBB COMPANY

Federal contract awards won by BRISTOL-MYERS SQUIBB COMPANY (UEI UFGKB2B71N12), 2022–2026 — public record from USAspending.

Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

62
awards
5
expiring in 12 months
1
agency

How their work has changed

Mostly the same kind of work as two years ago.

Share of their contracts in each industry code: the last 24 months compared with the 24 months before, as of Nov 21, 2026. Shown only for companies with at least 5 contracts in each period.

Category award history

74 category awards to a new vendor (same agency and NAICS code, not this contract's own history) — latest: SAGENT PHARMACEUTICALS, INC took Department of Veterans Affairs 325412 work from BRISTOL-MYERS SQUIBB COMPANY (Nov 9, 2026).

Agencies buying from BRISTOL-MYERS SQUIBB COMPANY

What BRISTOL-MYERS SQUIBB COMPANY has provided

Awards

CAMZYOS AND POMALYST
Department of Veterans Affairs · $1,049,820 · Oct 1, 2026
BREYANZI INJECTION
Department of Veterans Affairs · $364,139 · Sep 11, 2026
BREYANZI INJECTION MM8684
Department of Veterans Affairs · $364,139 · Aug 27, 2026
ABECMA INJECTION
Department of Veterans Affairs · $378,650 · Aug 10, 2026
MAVACAMTEN (CAMZYOS) AND POMALIDOMIDE (POLMALYST)
Department of Veterans Affairs · $300,000 · Aug 2, 2026
BREYANZI CAR-T TRANSPLANT.
Department of Veterans Affairs · $364,139 · Jun 26, 2026
BREYANZI CAR-T
Department of Veterans Affairs · $364,139 · Jun 22, 2026
BREYANZI CAR T
Department of Veterans Affairs · $364,139 · Jun 18, 2026
BREYANZI CAR T - TRANSPLANT
Department of Veterans Affairs · $364,139 · Jun 18, 2026
BREYANZI CAR T - TRANSPLANT
Department of Veterans Affairs · $364,139 · Jun 18, 2026
BREYANZI CAT-T TRANSPLANT
Department of Veterans Affairs · $364,139 · Jun 11, 2026
BREAYNAZI FOR CAR-T TRANSPLANT MEDICATION
Department of Veterans Affairs · $364,139 · Jun 2, 2026
BREYANZI CAR T-TRANSPLANT
Department of Veterans Affairs · $364,139 · May 29, 2026
BREYANZI
Department of Veterans Affairs · $335,043 · Mar 16, 2026
ABECMA FOR CAR-T
Department of Veterans Affairs · $378,650 · Mar 13, 2026
REVLIMID
Department of Veterans Affairs · No current value reported · Feb 5, 2026
MAVACAMTEN (CAMZYOS) AND POMALIDOMIDE (POLMALYST)
Department of Veterans Affairs · $371,280 · Jan 29, 2026
BREYANZI CAR T CELL THERAPY
Department of Veterans Affairs · $335,043 · Jan 21, 2026
BPA FOR CAMZYOS, POMALYST, AND THALOMID
Department of Veterans Affairs · No current value reported · Jan 16, 2026
REVLIMID, POMALYST, CAMZYOS SPECIALTY PHARMACEUTICALS
Department of Veterans Affairs · $848,445 · Dec 31, 2025
BREYANZI FOR CAR T
Department of Veterans Affairs · $335,043 · Dec 15, 2025
ABECMA TRANSPLANT DRUG
Department of Veterans Affairs · $338,933 · Dec 5, 2025
BREYANZI CAR T THERAPY FOR TVHS TRANSPLANT CENTER
Department of Veterans Affairs · $335,043 · Oct 27, 2025
ABECMA FOR CAR-T
Department of Veterans Affairs · $338,933 · Oct 9, 2025